-
1
-
Optimization of ex vivo hematopoietic stem cell expansion in intermittent dynamic cultures
-
Choi, Yong-Soo;
Noh, Sang-Eun;
Lim, Sang-Min;
Kim, Dong-il;
Department of Applied Bioscience, CHA University, Seoul, 135-081 Korea;
CHA Bio & Diostech, Seoul, 135-833 Korea;
Department of Biological Engineering, Inha University, Incheon, 402-751 Korea;
Department of Biological Engineering, Inha University, Incheon, 402-751 Korea;
(Biotechnology letters. : a monthly journal for the rapid communication of results and developments in all aspects of biotechnology,
v.32,
2010,
pp.1969-1975)
-
2
-
건강한 남성 지원자에서 위산분비억제제 레바넥스<TEX>$^{ circledR}$</TEX>[revaprazan, YH1885] 정의: 반복투여가 내분비 기능에 미치는 영향 평가
-
Shon, Ji-Hong;
Ryu, Ji-Young;
Sunwoo, Yu-Eun;
Jang, Jung-Hoon;
Kim, Eun-Young;
Joo, Young-Don;
Seol, Sang-Young;
Song, Keun-Seog;
Moon, Byoung-Seok;
Joo, Sang-Aun;
Shin, Jae-Gook;
인제대학교 의과대학 약리학교실,부산백병원 임상약리과,부산백병원 임상시험센터;
인제대학교 의과대학 약리학교실,부산백병원 임상약리과;
인제대학교 의과대학 약리학교실,부산백병원 임상약리과;
부산백병원 임상시험센터;
인제대학교 의과대학 약리학교실,부산백병원 임상약리과,부산백병원 임상시험센터;
부산백병원 내과학교실;
부산백병원 임상시험센터,부산백병원 내과학교실;
(주)유한양행;
(주)유한양행;
(주)유한양행;
인제대학교 의과대학 약리학교실,부산백병원 임상약리과,부산백병원 임상시험센터;
(臨床藥理學會誌 = The journal of Korean society for Clinical Pharmacology and Therapeutics,
v.13,
2005,
pp.157-166)
-
3.
- 치주질환과 대장선종 발생의 연관성
- 김건우
-
차의과학대학교 대학원, 국내석사,
, 2018
-
4
-
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study
-
Corazzelli, G.;
Russo, F.;
Capobianco, G.;
Marcacci, G.;
Cioppa, P. Della;
Pinto, A.;
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, Naples, Italy;
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, Naples, Italy;
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, Naples, Italy;
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, Naples, Italy;
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, Naples, Italy;
Correspondence to: Dr A. Pinto, Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Via Mariano Semmola, I-80131, Naples, Italy. Tel: +39-081-5903-382;
Fax: +39-081-5903-833;
E-mail: apinto.int.napoli@tin.it;
(Annals of oncology : official journal of the European Society for Medical Oncology,
v.17,
2006,
pp.iv18-iv24)
-
5
-
Prevalence Of HIV, Syphilis, Hepatitis B, and Hepatitis C Among Entrants to Maryland Correctional Facilities
-
Solomon, Liza;
Flynn, Colin;
Muck, Kelly;
Vertefeuille, John;
Dr. Solomon, Mr. Flynn, and Ms. Muck are with the Maryland Department of Health and Mental Hygiene, AIDS Administration, Baltimore. Dr. Vertefeuille is with the University of Maryland, Baltimore.;
Dr. Solomon, Mr. Flynn, and Ms. Muck are with the Maryland Department of Health and Mental Hygiene, AIDS Administration, Baltimore. Dr. Vertefeuille is with the University of Maryland, Baltimore.;
Dr. Solomon, Mr. Flynn, and Ms. Muck are with the Maryland Department of Health and Mental Hygiene, AIDS Administration, Baltimore. Dr. Vertefeuille is with the University of Maryland, Baltimore.;
Dr. Solomon, Mr. Flynn, and Ms. Muck are with the Maryland Department of Health and Mental Hygiene, AIDS Administration, Baltimore. Dr. Vertefeuille is with the University of Maryland, Baltimore.;
(Journal of urban health : bulletin of the New York Academy of Medicine,
v.81,
2004,
pp.25-37)
-
6
-
Analysis of 30 synthetic cannabinoids in serum by liquid chromatography‐electrospray ionization tandem mass spectrometry after liquid‐liquid extraction
-
Kneisel, Stefan;
Auwä
rter, Volker;
;
(Journal of mass spectrometry : JMS,
v.47,
2012,
pp.825-835)
-
7
-
Patent Reviews: 3,868,173; 3,868,174; 3,871,741; 3,889,208; 3,894,789; 3,916,338; 3,934,211; 3,936,155; 3,936,772; 3,938,172; 3,940,713; 3,942,132; 3,946,334; 3,949,319; 3,969,016; 3,969,573; 3,974,376; 3,977,767; 3,977,018; 3,977,793; 3,978,458; 3,980,390; 3,980,392; 3,980,395; 3,981,591; 3,982,816; 3,982,818; 3,982,833; 3,990,770; 3,992,081; 3,992,083; 3,992,084; 3,992,623; 3,994,573; 3,994,576; 3,998,528; 3,998,529; 4,001,840; 4,002,406; 4,002,407; 4,005,285; 4,009,934; 4,009,938; 4,009,945; 4,009,956; 4,013,347; 4,014,608; 4,015,896; 4,015,897; 4,017,147; 4,017,148; 4,017,163; 4,017,171; 4,018,509; 4,018,512; 4,018,523; 4,019,157; 4,021,099; 4,025,157; 4,025,199; 4,025,783; 4,027,951; 4,027,952; 4,027,976; 4,028,544; 4,028,548; 4,028,719; 4,029,396; 4,029,419; 4,030,805; 4,033,052; 4,033,667; 4,033,674; 4,033,688; 4,037,934; 4,040,039; 4,040,056; 4,040,720; 4,042,295; 4,045,127; 4,045,128; 4,046,459; 4,046,460; 4,048,587; 4,050,778; 4,050,779; 4,052,121; 4,054,369; 4,055,378; 4,056,306; 4,056,310; 4,056,311; 4,057,328; 4,057,330; 4,059,340; 4,059,342; 4,059,344; 4,059,348; 4,060,306; 4,060,312; 4,061,418
-
Lovell, D. J.;
;
(Applied optics,
v.17,
1978,
pp.1468)
1